vs
Side-by-side financial comparison of Azenta, Inc. (AZTA) and ROGERS CORP (ROG). Click either name above to swap in a different company.
ROGERS CORP is the larger business by last-quarter revenue ($200.5M vs $148.6M, roughly 1.3× Azenta, Inc.). ROGERS CORP runs the higher net margin — 2.2% vs -10.4%, a 12.6% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs 0.8%). Azenta, Inc. produced more free cash flow last quarter ($14.7M vs $1.1M). Over the past eight quarters, Azenta, Inc.'s revenue compounded faster (4.4% CAGR vs -3.3%).
Azenta, was founded in 1978, and is based in Chelmsford, Massachusetts, United States. The company is a provider of life sciences services including genomics, cryogenic storage, automation, and informatics.
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
AZTA vs ROG — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $148.6M | $200.5M |
| Net Profit | $-15.4M | $4.5M |
| Gross Margin | 42.9% | 32.2% |
| Operating Margin | -4.9% | — |
| Net Margin | -10.4% | 2.2% |
| Revenue YoY | 0.8% | 5.2% |
| Net Profit YoY | -15.7% | 421.4% |
| EPS (diluted) | $-0.34 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $148.6M | $201.5M | ||
| Q3 25 | $159.2M | $216.0M | ||
| Q2 25 | $143.9M | $202.8M | ||
| Q1 25 | $143.3M | $190.5M | ||
| Q4 24 | $147.4M | $192.2M | ||
| Q3 24 | $150.6M | $210.3M | ||
| Q2 24 | $144.3M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-15.4M | $4.6M | ||
| Q3 25 | $50.9M | $8.6M | ||
| Q2 25 | $-48.0M | $-73.6M | ||
| Q1 25 | $-47.7M | $-1.4M | ||
| Q4 24 | $-11.0M | $-500.0K | ||
| Q3 24 | $-6.6M | $10.7M | ||
| Q2 24 | $-6.6M | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | 42.9% | 31.5% | ||
| Q3 25 | 45.4% | 33.5% | ||
| Q2 25 | 46.2% | 31.6% | ||
| Q1 25 | 43.8% | 29.9% | ||
| Q4 24 | 46.7% | 32.1% | ||
| Q3 24 | 45.5% | 35.2% | ||
| Q2 24 | 44.8% | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | -4.9% | 3.5% | ||
| Q3 25 | 1.2% | 7.3% | ||
| Q2 25 | -1.3% | -33.3% | ||
| Q1 25 | -12.7% | -0.2% | ||
| Q4 24 | -5.9% | -6.6% | ||
| Q3 24 | -3.1% | 6.9% | ||
| Q2 24 | -4.9% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | -10.4% | 2.3% | ||
| Q3 25 | 32.0% | 4.0% | ||
| Q2 25 | -33.4% | -36.3% | ||
| Q1 25 | -33.3% | -0.7% | ||
| Q4 24 | -7.5% | -0.3% | ||
| Q3 24 | -4.4% | 5.1% | ||
| Q2 24 | -4.5% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.34 | $0.20 | ||
| Q3 25 | $1.12 | $0.48 | ||
| Q2 25 | $-1.05 | $-4.00 | ||
| Q1 25 | $-1.04 | $-0.08 | ||
| Q4 24 | $-0.25 | $-0.04 | ||
| Q3 24 | $-0.25 | $0.58 | ||
| Q2 24 | $-0.12 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $336.6M | $195.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $1.2B |
| Total Assets | $2.1B | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $336.6M | $197.0M | ||
| Q3 25 | $279.8M | $167.8M | ||
| Q2 25 | $270.0M | $157.2M | ||
| Q1 25 | $253.6M | $175.6M | ||
| Q4 24 | $377.5M | $159.8M | ||
| Q3 24 | $280.0M | $146.4M | ||
| Q2 24 | $336.5M | $119.9M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $1.7B | $1.2B | ||
| Q3 25 | $1.7B | $1.2B | ||
| Q2 25 | $1.7B | $1.2B | ||
| Q1 25 | $1.7B | $1.3B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.8B | $1.3B | ||
| Q2 24 | $2.0B | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.1B | $1.4B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.0B | $1.5B | ||
| Q1 25 | $2.0B | $1.5B | ||
| Q4 24 | $2.0B | $1.5B | ||
| Q3 24 | $2.1B | $1.5B | ||
| Q2 24 | $2.3B | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $20.8M | $5.8M |
| Free Cash FlowOCF − Capex | $14.7M | $1.1M |
| FCF MarginFCF / Revenue | 9.9% | 0.5% |
| Capex IntensityCapex / Revenue | 4.2% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | $30.9M | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $20.8M | $46.9M | ||
| Q3 25 | $2.2M | $28.9M | ||
| Q2 25 | $25.8M | $13.7M | ||
| Q1 25 | $14.4M | $11.7M | ||
| Q4 24 | $29.8M | $33.7M | ||
| Q3 24 | $17.7M | $42.4M | ||
| Q2 24 | $9.8M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | $14.7M | $42.2M | ||
| Q3 25 | $-5.7M | $21.2M | ||
| Q2 25 | $15.0M | $5.6M | ||
| Q1 25 | $7.0M | $2.1M | ||
| Q4 24 | $22.0M | $18.3M | ||
| Q3 24 | $8.3M | $25.2M | ||
| Q2 24 | $1.3M | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 9.9% | 20.9% | ||
| Q3 25 | -3.6% | 9.8% | ||
| Q2 25 | 10.4% | 2.8% | ||
| Q1 25 | 4.9% | 1.1% | ||
| Q4 24 | 15.0% | 9.5% | ||
| Q3 24 | 5.5% | 12.0% | ||
| Q2 24 | 0.9% | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 4.2% | 2.3% | ||
| Q3 25 | 4.9% | 3.6% | ||
| Q2 25 | 7.5% | 4.0% | ||
| Q1 25 | 5.2% | 5.0% | ||
| Q4 24 | 5.3% | 8.0% | ||
| Q3 24 | 6.2% | 8.2% | ||
| Q2 24 | 5.9% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | 0.04× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AZTA
| Multiomics | $67.2M | 45% |
| Core Products | $47.6M | 32% |
| Sample Repository Solutions | $33.8M | 23% |
ROG
Segment breakdown not available.
